Product/Service

Novel TRAIL and TRAIL Receptor Products

Source: ALEXIS Biochemicals
Alexis® Biochemicals now offers a number of innovative new products to aid the study of TNF-related apoptosis-inducing ligand (TRAIL) mediated apoptosis

Alexis® Biochemicals now offers a number of innovative new products to aid the study of TNF-related apoptosis-inducing ligand (TRAIL) mediated apoptosis. This comprehensive family of TRAIL and TRAIL-Receptor products includes recombinant TRAIL proteins and monoclonal antibodies to TRAIL and TRAIL receptors, as well as antibodies to important downstream signaling molecules such as FLIP, FADD, and Caspase-8.

Among the many new products in the Alexis Biochemicals' line are KillerTRAIL™, a highly active recombinant protein that binds to both human and mouse TRAIL receptors and Anti-TRAIL MAb 2E5 which neutralizes the activity of KillerTRAIL.

As with all the company's products, these TRAIL and TRAIL-receptor products are competitively priced, available from stock for immediate shipment, and fully supported with comprehensive technical and applications assistance.

ALEXIS Biochemicals, 6181 Cornerstone Court East, Suite 103, San Diego, CA 92121-4727. Tel: 858-658-0065; Fax: 858-658-9224.